Dare Bioscience Files 8-K Report
Ticker: DARE · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1401914
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
Dare Bioscience filed an 8-K, mostly boilerplate with exhibits. Keep an eye out for more details.
AI Summary
On July 14, 2025, Dare Bioscience, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that Dare Bioscience, Inc. is providing updated information to the SEC, which could include financial details or other material events relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific material events or financial disclosures that would immediately impact risk.
Key Players & Entities
- Dare Bioscience, Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3655 Nobel Drive, Suite 260, San Diego, CA 92122 (address) — Principal Executive Offices
- Cerulean Pharma Inc. (company) — Former company name
- Tempo Pharmaceuticals Inc (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Dare Bioscience, Inc.?
The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, covering Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported is dated July 14, 2025.
In which state is Dare Bioscience, Inc. incorporated?
Dare Bioscience, Inc. is incorporated in Delaware.
What are the former names of Dare Bioscience, Inc. mentioned in the filing?
The former names mentioned are Cerulean Pharma Inc. and Tempo Pharmaceuticals Inc.
What is the principal executive office address for Dare Bioscience, Inc.?
The principal executive office address is 3655 Nobel Drive, Suite 260, San Diego, CA 92122.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Dare Bioscience, Inc. (DARE).